Julian Marcon
Overview
Explore the profile of Julian Marcon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Nellessen T, Ebner B, Pyrgidis N, Ledderose S, Kretschmer A, Marcon J, et al.
Viruses
. 2023 Jun;
15(6).
PMID: 37376564
Introduction: The association between human papilloma virus (HPV) and the pathogenesis of prostate cancer (PCa) is still controversial. Existing studies often lack information about clinical risk factors, are limited by...
22.
Chaloupka M, Apfelbeck M, Pyrgidis N, Marcon J, Weinhold P, Stief C
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831608
Modern risk stratification of prostate cancer (PCa) allows for prediction of advanced disease with a high level of certainty. We aimed to evaluate a prospective series of patients undergoing radical...
23.
Berg E, Stief C, Marcon J
MMW Fortschr Med
. 2022 Sep;
164(15):39-40.
PMID: 36064921
No abstract available.
24.
Rodler S, Buchner A, Eismann L, Schulz G, Marcon J, Ledderose S, et al.
Res Rep Urol
. 2022 Aug;
14:281-290.
PMID: 35937307
Purpose: Absence of tumor in the final histopathology after radical cystectomy (RC) is a rare but potentially favorable outcome. Therefore, we aimed to analyze outcomes and prognostic factors of patients...
25.
Volz Y, Ebner B, Pfitzinger P, Berg E, Lellig E, Marcon J, et al.
Infection
. 2022 Apr;
50(6):1499-1505.
PMID: 35471630
Objective: To determine the impact of asymptomatic bacteriospermia on semen quality in subfertile men. Methods: We conducted a retrospective, single-centre cohort study in 1300 subfertile men. In those diagnosed with...
26.
Mittlmeier L, Todica A, Gildehaus F, Unterrainer M, Beyer L, Brendel M, et al.
Eur J Nucl Med Mol Imaging
. 2021 Oct;
49(5):1711-1720.
PMID: 34708249
Background: Ga-EMP-100 is a novel positron emission tomography (PET) ligand that directly targets tumoral c-MET expression. Upregulation of the receptor tyrosin kinase c-MET in renal cell carcinoma (RCC) is correlated...
27.
Mano R, Duzgol C, Ganat M, Goldman D, Blum K, Silagy A, et al.
Urol Oncol
. 2021 Sep;
39(11):791.e17-791.e24.
PMID: 34580025
Objective: Recurrent genomic alterations in clear cell renal cell carcinoma (ccRCC) have been associated with treatment outcomes; however, current preoperative predictive models do not include known genetic predictors. We aimed...
28.
Spek A, Graser A, Casuscelli J, Szabados B, Rodler S, Marcon J, et al.
Urol Oncol
. 2021 Sep;
40(1):13.e1-13.e8.
PMID: 34535355
Purpose: To evaluate the role of dynamic contrast-enhanced CT (DCE-CT) as an independent non-invasive biomarker in predicting long term outcome in patients with metastatic renal cell carcinoma (mRCC) on antiangiogenic...
29.
Stock S, Marcon J, Chaloupka M, Becker A, Kunz W, Ormanns S, et al.
Case Rep Oncol
. 2021 May;
14(1):681-689.
PMID: 34054461
Testicular cancer is a rare disease; however, cure rates are high for all tumor stages. Mostly, the disease is diagnosed in an early (local) stage. We report the case of...
30.
Silagy A, Attalla K, DiNatale R, Weiss K, Weng S, Mano R, et al.
World J Urol
. 2021 Mar;
39(9):3359-3365.
PMID: 33779820
Purpose: Cytoreductive nephrectomy (CN) benefits a subset of patients with metastatic renal cell carcinoma (mRCC), however proper patient selection remains complex and controversial. We aim to characterize urologists' reasons for...